Home · Open Lab · Lot RGX-26-TESAMORELIN-753
RGX-26-TESAMORELIN-753Superseded
Tesamorelin · 20 MG · Endocrine Research · COA NS-2026-05169

Release test results

99.646%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 20.12 mg
Related impurities (total)0.354%
Endotoxin<1.0 EU/mg
HPLC retention time4.89 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundTesamorelin
Presentation20 MG
Lot numberRGX-26-TESAMORELIN-753
COA numberNS-2026-05169
Test date06 Sep 2026
Release date09 Sep 2026
Independent labNordicstar Labs
StatusSuperseded

Tesamorelin — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-TESAMORELIN-65410 MGSep 8, 202699.684%Superseded
RGX-26-TESAMORELIN-104610 MGSep 6, 202699.753%Current
RGX-26-TESAMORELIN-75410 MGSep 6, 202699.736%Superseded
RGX-26-TESAMORELIN-753 this lot20 MGSep 6, 202699.646%Superseded
RGX-26-TESAMORELIN-65320 MGSep 5, 202699.667%Superseded
RGX-26-TESAMORELIN-104720 MGSep 4, 202699.584%Current
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →